| GC33507-10mM(1mLinDMSO) |
|
3147-14-6 |
|
0 |
C17H14N2O5S |
|
|
|
| GC33506-1mg |
|
77573-43-4 |
|
0 |
C23H32O5 |
|
|
|
| GC33505-5mg |
|
86530-28-1 |
β-Apo-13-carotenone D3 (D’Orenone D3)
|
0 |
C18H23D3O |
|
|
|
| GC33505-1mg |
|
86530-28-1 |
β-Apo-13-carotenone D3 (D’Orenone D3)
|
0 |
C18H23D3O |
|
|
|
| GC33505-10mM(1mLinDMSO) |
|
86530-28-1 |
β-Apo-13-carotenone D3 (D’Orenone D3)
|
0 |
C18H23D3O |
|
|
|
| GC33504-200mg |
|
3025-96-5 |
4-Acetamidobutanoic acid (N-acetyl GABA)
|
0 |
C6H11NO3 |
|
|
|
| GC33504-10mM(1mLinWater) |
|
3025-96-5 |
4-Acetamidobutanoic acid (N-acetyl GABA)
|
0 |
C6H11NO3 |
|
|
|
| GC33503-10mg |
|
957230-65-8 |
Afegostat D-Tartrate (D-Isofagomine (D-Tartrate))
|
0 |
C10H19NO9 |
|
|
|
| GC33503-5mg |
|
957230-65-8 |
Afegostat D-Tartrate (D-Isofagomine (D-Tartrate))
|
0 |
C10H19NO9 |
|
|
|
| GC33503-1mg |
|
957230-65-8 |
Afegostat D-Tartrate (D-Isofagomine (D-Tartrate))
|
0 |
C10H19NO9 |
|
|
|
| GC33502-5mg |
|
4 |
|
0 |
C8H13N3O6 |
|
|
|
| GC33502-10mM(1mLinDMSO) |
|
4 |
|
0 |
C8H13N3O6 |
|
|
|
| GC33501-10mM(1mLinDMSO) |
|
76-49-3 |
|
0 |
C12H20O2 |
|
|
|
| GC33500-10mg |
|
1281816-04-3 |
Lys-SMCC-DM1 (Lys-Nε-MCC-DM1)
|
0 |
C53H75ClN6O15S |
|
|
|
| GC33500-5mg |
|
1281816-04-3 |
Lys-SMCC-DM1 (Lys-Nε-MCC-DM1)
|
0 |
C53H75ClN6O15S |
|
|
|
| GC33500-1mg |
|
1281816-04-3 |
Lys-SMCC-DM1 (Lys-Nε-MCC-DM1)
|
0 |
C53H75ClN6O15S |
|
|
|
| GC33500-10mM(1mLinDMSO) |
|
1281816-04-3 |
Lys-SMCC-DM1 (Lys-Nε-MCC-DM1)
|
0 |
C53H75ClN6O15S |
|
|
|
| GC33499-5mg |
|
548783-71-7 |
Fexofenadine D6 (MDL-16455 D6)
|
0 |
C32H33D6NO4 |
|
|
|
| GC33499-10mg |
|
548783-71-7 |
Fexofenadine D6 (MDL-16455 D6)
|
0 |
C32H33D6NO4 |
|
|
|
| GC33498-500mg |
|
6747-15-5 |
D,L-3-Indolylglycine (α-Amino-1H-indole-3-acetic acid)
|
0 |
C10H10N2O2 |
|
|
|
